Printer Friendly

Articles from Dermatology News (October 1, 2018)

1-63 out of 63 article(s)
Title Author Type Words
5 HIPAA myths in the digital age. Gallegos, Alicia 1027
AD severity linked to S. aureus clonal complex types. Dotinga, Randy 493
Allergic contact dermatitis. Martin, Donna Bilu 428
Allergic reaction in a toddler attributed to potty seat. Pivovarov, Jill D. 321
Alopecia areata linked to mental health disorders. Kling, Jim 475
Assess a vesiculopustular lesion in three steps. Brunk, Doug 301
Bertilimumab granted orphan drug status, studies underway. Mechcatie, Elizabeth 204
Biologics bring potential for long-term remission off treatment. Jancin, Bruce Clinical report 962
Burnout may jeopardize patient care. Craven, Jeff 867
CDC study takes baseline on EHR interoperability. Franki, Richard 357
Certain skin conditions signal potential overgrowth disorder. Brunk, Doug 1105
Cloves. Baumann, Leslie S. 1542
Cutaneous lesions? Consider C. diphtheriae in those with foreign travel. Worcester, Sharon 524
CV risk factors go undiagnosed, untreated in many psoriatic patients. Laubach, Lori 552
Dermatologists continue to prefer urban areas. Splete, Heidi Clinical report 695
Don't forget about OSHA. Eastern, Joseph S. 744
E/M comments may fall on deaf ears at CMS. Twachtman, Gregory 1140
Elderly patients with psoriasis can benefit from biologies with low rates of adverse events. Sullivan, Michele G. 922
Expert shares tips for laser treatment of pigmented lesions. Brunk, Doug 497
Extended propranolol use boosts success in high-risk hemangioma. Rajaraman, Madhu 490
Family history of psoriasis and PsA predicts disease phenotype. Andrews, Nick 566
FDA approves certolizumab label update for pregnancy, breastfeeding. Laubach, Lori 794
Genital psoriasis is the worst: Patients sound off. Jancin, Bruce 722
Global incidence of rosacea estimated to be over 5%. Splete, Heidi 365
Guselkumab crushes skin disease in psoriatic arthritis patients. Jancin, Bruce 855
HIV-associated Kaposi sarcoma responds to checkpoint inhibitors. Pass, Will 368
Is PASI 100 the new benchmark in psoriasis? Jancin, Bruce 1179
Itraconazole for BCC: Does it work? Jancin, Bruce 440
LASER TATTOO REMOVAL: How to get the best results. Brunk, Doug 1305
Make a PEST of your psoriasis patients. Jancin, Bruce 619
Medicare ACOs were able to work without financial penalties. Twachtman, Gregory 415
Medicare donut hole: Fewer enrollees, more spending in 2016. Franki, Richard 332
Medication app boosts psoriasis patients' short-term adherence. Splete, Heidi 654
Meta-analysis: Lifestyle changes improve psoriasis. Jancin, Bruce 764
Minorities less likely to seek treatment for psoriasis. Splete, Heidi 931
Mohs underutilized for melanoma of head and neck. Jancin, Bruce 414
Most PsA patients discontinue initial biologic within 12 months. Bowser, Andrew D. 598
Nivolumab plus ipilimumab effective in melanoma brain metastases. Bowser, Andrew D. 634
Online psoriasis consultations shown equivalent to office visits. Zoler, Mitchel L. 541
Orodental issues associated with facial port-wine stains. Brunk, Doug 573
Patient survey results highlight disease burden in atopic dermatitis. Bowser, Andrew D. 608
Poor gut health tied to increased risk for systemic disease. Brunk, Doug 836
PPACMAN aims to advance the combined rheum-derm clinic approach. Mechcatie, Elizabeth 313
Produce and promises. Coldiron, Brett M. 716
Professional psychology. Rockoff, Alan 794
Psoriasis and Psoriatic Arthritis. Armstrong, April W.; Menter, Alan 556
Psoriasis duration reflects cardiovascular event risk. Jancin, Bruce 696
Psoriasis therapy with biologies not linked to increased cancer risk. Nellist, Catherine Cooper 679
Red flag raised on CMS indication-based formulary. Twachtman, Gregory 629
Reflectance confocal microscopy: The future looks bright. Jancin, Bruce 549
Risk factors for progression include family history. Craven, Jeff Clinical report 580
Skin signs may be good omens during cancer therapy. Osterweil, Neil 566
Slowing down. Benabio, Jeffrey 682
Smart prescribing that avoids resistance. Brunk, Doug 921
The evolving role of expert testimony. Tan, S.Y. 1264
Three fraud and abuse triggers to consider. Gallegos, Alicia 832
Topical corticosteroid-retinoid combination effective in moderate to severe psoriasis. Nogrady, Bianca 678
Topical ozenoxacin effective in phase 3 trial. Bowser, Andrew D. 402
Vitamin [B.sub.5] enhances doxycycline's antiacne effects. Jancin, Bruce 544
Voters want to protect people with preexisting conditions. Franki, Richard 337
When treating the lower face and neck, 'don't forget the platysma muscle'. Brunk, Doug 592
Whole-body cryotherapy. Wesley, Naissan; Talakoub, Lily 821
Zika virus infection: Novel assay extends diagnostic window. Worcester, Sharon 566

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters